MedCity News

NOVEMBER 20, 2024

We cannot change the fact that some patients must take multiple drugs, but we can certainly change how we manage it with careful coordination and communication among healthcare providers, and personalized medicine practices such as pharmacogenomics.

Management 297

Management Medical Healthcare Provider Medicine 297

MedCity News

JULY 27, 2022

A panel discussion on the future of digital medicine highlighted some of the collaborations taking place between pharma companies and digital health, as well as some of the challenges facing the push towards mainstream implementation.

Medicine 302

Medicine Pharma Patients 302

MedCity News

NOVEMBER 10, 2023

As the industry moves towards more personalized medicine, pharmacogenomics could play a key role in keeping patients healthier longer and in getting them viable treatments for their unique genetic profile.

Medicine 290

Medicine Patients Biopharma 290

MedCity News

JULY 15, 2024

Revolution Medicines drug RMC-6236 increased progression-free survival in patients with advanced cases of pancreatic ductal adenocarcinoma. The post Positive Data in Pancreatic Cancer Pave Way for Pivotal Test of Revolution Medicines Drug appeared first on MedCity News.

Medicine 278

Medicine Patients Biopharma 278

MedCity News

APRIL 11, 2023

Culturally competent behavioral health provider ReKlame Health is rolling out an in-home program for addiction medicine care in New York City.

Medicine 289

Medicine Patients 289

MedCity News

MAY 10, 2023

Medical Affairs plays a critical role when it comes to driving adherence to evidence-based medicine (EBM) – the principle that clinical decisions should be informed by the best available scientific evidence, along with clinical experience and patient preference.

Medicine 306

Medicine Medical Patients Biopharma 306

Fierce Pharma

DECEMBER 12, 2023

Over the past several years, drug shortages have vexed doctors and patients on both sides of the Atlantic, prompting lawmakers and government agencies to take action in both Europe and the U.S. Tuesday, the European Medicines Agency laid out a list of more than 300 critical generic drugs that could fall prey to future shortages.

Medicine 331

Medicine Doctors Government Patients 331

MedCity News

MAY 10, 2023

“Precision medicine” is a term we have heard a lot over the last two decades, […]

Medicine 298

Medicine Patients 298

Fierce Pharma

DECEMBER 2, 2024

The FDA is investigating reports of patients develo | The FDA is investigating reports of patients developing blood cancer after receiving bluebird bio’s gene therapy Skysona and is evaluating the need for “further regulatory action,” the U.S. agency said last week.

FDA 250

FDA Medicine Patients 250

MedCity News

OCTOBER 23, 2023

For example, all models tried to justify race-based medicine when asked questions about calculating patients’ kidney function and lung capacity — two areas where race-based medicine practices used to be common but have since been scientifically refuted.

Medicine 290

Medicine Patients Healthcare Healthcare 290

MedCity News

DECEMBER 2, 2022

Health system leaders believe that improving patient access should be their top priority when strategically planning for 2023, according to a new report from the KLAS Research and UPMC’s Center for Connected Medicine.

Patients 321

Patients Medicine 321

MedCity News

NOVEMBER 7, 2023

Baylor Medicine teamed up with Luna to launch a program expanding access to in-home physical therapy for patients in the Houston area. Luna, a provider of in-home physical therapy, has similar partnerships with more than two dozen health systems.

Medicine 290

Medicine Marketing Patients Healthcare 290

Fierce Pharma

DECEMBER 4, 2024

Following its endorsement of Eli Lilly’s obesity medicine tirzepatide, England’s National Institute for Health and Care Excellence (NICE) has laid out plans for an unprecedented phased rollout that | Roughly 220,000 people in England will be eligible for the drug during the three-year launch phase.

Patients 173

Patients Medicine 173

Fierce Pharma

OCTOBER 28, 2024

While Astellas’ Izervay and Apellis’ Syfovre battle for market share in geographic atrophy (GA) in the United States, both companies are struggling to reach patients in the indication in Europe.&nb

Medicine 233

Medicine Marketing Patients 233

MedCity News

SEPTEMBER 20, 2023

The art of processing and producing valuable data, empowers researchers to identify potential drug targets, predict drug interactions, and optimize clinical trial designs, reducing time and costs associated with research endeavors and ultimately bringing the best quality medicines to meet our needs at a faster pace.

Ethics 298

Ethics Medicine Pharmaceutical Pharmaceutical research 298

Fierce Pharma

MAY 28, 2024

A data breach at drug distributor Cencora has left sensitive information vulnerable, with patients on medicines from a dozen drugmakers potentially affected. | The potentially compromised data included patient information such as names and addresses, Cencora disclosed in letters to patients who may have been affected.

Patients 280

Patients Pharma Medicine 280

MedCity News

FEBRUARY 14, 2023

We’ve always known that patients are out there — but EHR data are the map we need to find them, connect with them, and ultimately engage them in the development of new medicines, therapies, and products that will safely serve everyone in need, regardless of race or ethnicity.

Patients 286

Patients Medicine 286

MedCity News

DECEMBER 19, 2023

It’s time to build the infrastructure needed to scale up inhaled gene therapies targeting cystic fibrosis, and to bolster investment that supports several key program components.

Medicine 331

Medicine Patients Biopharma 331

MedCity News

MAY 14, 2023

There is a huge opportunity for PBMs and health systems to use AI to help address the challenges surrounding the affordability and accessibility of medicines, from navigating formularies to resolving prior authorization. More automation in pharmacies and with ordering workflows is one piece of that puzzle.

Medical 349

Medical Patients Medicine Biopharma 349

MedCity News

FEBRUARY 20, 2025

Improving the identification and validation of disease-specific drug targets in a cell-type and patient-specific manner early on will not only reduce the failure rate and cost that is so inherent in current drug development processes but also allow the development of more effective precision medicines, improving patient outcomes.

Medicine 165

Medicine Patients Pharmaceutical Biopharma 165

MedCity News

OCTOBER 28, 2022

In fact, more than 10,000 patients have undergone this new treatment for certain types of leukemia, lymphoma. CAR-T has become increasingly recognized as an exciting and potentially paradigm-shifting treatment in the past five years. and multiple myeloma.

Medicine 334

Medicine FDA Patients Biopharma 334

PharmaVoice

AUGUST 21, 2023

Using real-time data, patient centricity and personalized medicine to accelerate clinical trials.

Patients 246

Patients Medicine 246

Contrarian Sales Techniques

NOVEMBER 19, 2024

Counterfeit medicines aren’t just a risk to patients’ health – they’re a blow to the industry’s reputation and our efforts to promote genuine, high-quality treatments. What Are Counterfeit Medicines? Counterfeit medicines are fake drugs that may contain incorrect ingredients, the wrong dose, or even harmful substances.

Medicine 52

Medicine Sales Pharma Doctors 52

MedCity News

JUNE 12, 2023

Penn Medicine recently published a study on the economics of providing telemedicine — it showed that when the health system began offering virtual urgent care services to its employees, the visits ended up being 23% less expensive to conduct than in-person appointments.

Medicine 287

Medicine Patients 287

PharmaVoice

OCTOBER 22, 2024

Leaders advancing health advocacy, DEI initiatives and better medicine access for patients.

Patients 189

Patients Medicine 189

MedCity News

OCTOBER 16, 2023

Called Microsoft Fabric, which was rolled out broadly in May, the announcement on October 10 marks the availability of Fabric’s capabilities specifically for the healthcare vertical – to clinicians, administrators but perhaps, most importantly, to patients. Lungs hyperinflated to clear. No pneumothorax or pleural eltusion.

Healthcare 317

Healthcare Healthcare Patients Doctors 317

MedCity News

JULY 17, 2022

With promises of more efficient and reliable diagnoses, future breakthroughs in personalized medicine and targeted therapeutics, and an expedited R&D lifecycle, industry leaders must be prepared to invest in quantum technologies to deliver better outcomes for their organizations and patients.

Healthcare 356

Healthcare Healthcare Medicine Patients 356

InCrowd

MARCH 15, 2023

“What is the single greatest thing you can provide your patients?” I tell both patients and students alike that if a health care provider does not educate their patients about lifestyle modifications; they are doing them a disservice. Answers range from basic to insightful. Compassion and advocacy are two that I now hear often.

Physicians 246

Physicians Patients Education Healthcare 246

MedCity News

NOVEMBER 13, 2024

Johnson & Johnson is suing the federal agencies overseeing the 340B program that makes discounted medicines more accessible to uninsured and underserved patients. J&J contends the Health Resources Services Administration can’t legally oppose its plan to implement a new rebate plan for certain 340B drugs.

Medicine 173

Medicine Patients Biopharma Pharma 173

World of DTC Marketing

MARCH 28, 2021

IN BRIEF: Doctors are not required to treat obese patients who won’t do anything to lose weight but the problem is more than reminding patients they need to get exercise and drop pounds. But what about patients who make no effort to lose weight? Medicare and Medicaid patients specifically cost $61.8

Doctors 250

Doctors Patients Insurance Physicians 250

MedCity News

OCTOBER 1, 2023

Weaving companionship into health care as we would a blockbuster drug can help us circumvent expensive healthcare services like emergency department visits and hospitalizations.

Prescription 317

Prescription Medicine Healthcare Healthcare 317

MedCity News

JANUARY 28, 2024

While pharmaceutical companies continue to raise list prices year-over-year, we work behind the scenes to fight the trend by driving competition, negotiating with drugmakers and incentivizing the use of less expensive medicines that deliver the same clinical value.

Competition 325

Competition Medicine Pharma Patients 325

MedCity News

JANUARY 10, 2023

It also provides tools for patients to easily access their genetic information. The company provides the software infrastructure needed for health systems, clinics, drugmakers and payers to launch and scale genomic programs.

Patients 325

Patients Medicine 325

MedCity News

FEBRUARY 28, 2024

This Rare Disease Day is an opportunity to raise awareness of the challenges those living with a rare disease face, and why there’s reason to hope, thanks to advances in science that could potentially change the lives of millions of patients.

Medicine 288

Medicine Patients Biopharma 288

Fierce Pharma

AUGUST 24, 2023

mg dose bested placebo at reducing symptoms and physical limitations in patients with obesity and heart failure with preserved ejection fraction. The drug also led to greater improvements in exercise function and more weight loss versus a dummy drug, according to study results published in The New England Journal of Medicine Friday.

Patients 232

Patients Medicine 232

MedCity News

SEPTEMBER 22, 2022

A Biogen drug designed for a genetically defined form of amyotrophic lateral sclerosis led to patient improvement at a 12- month analysis, according to data now published in the New England Journal of Medicine.

FDA 312

FDA Medicine Patients Biopharma 312

MedCity News

MARCH 1, 2023

Eli Lilly is slashing prices for its insulin products and capping a patient’s monthly out-of-pocket costs at $35. But a financial analyst notes that the company can afford to cut prices on older medicines like insulin because the strategy will help it maintain pricing power for innovative new drugs.

Medicine 263

Medicine Patients Insurance Biopharma 263